Dovitinib (TKI258) in the Treatment of Patients With Relapsed Glioblastoma (Q61975177)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dovitinib (TKI258) in the Treatment of Patients With Relapsed Glioblastoma |
clinical trial |
Statements
TKI258 (English)
0 references
The Multi-targeted Tyrosine Kinase Inhibitor Dovitinib (TKI258) in the Treatment of Patients With Relapsed Glioblastoma (English)
0 references
October 2013
0 references
November 2016
0 references
12
0 references
18 year
0 references
100 year
0 references